| Serial Number | 97301774 |
| Word Mark | WYVERNA THERAPEUTICS |
| Filing Date | Tuesday, March 8, 2022 |
| Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
| Status Date | Monday, February 19, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, January 24, 2023 |
| Disclaimer with Predetermined Text | "THERAPEUTICS" |
| Goods and Services | Clinical research in the field of RNA therapeutics; Medical research; Medical research services; Medical and scientific research, namely, conducting clinical trials for others; Pharmaceutical product evaluation; Pharmaceutical products development; Pharmaceutical research and development; Scientific investigations for medical purposes; Scientific laboratory services; Scientific research; Scientific research and development; Conducting scientific feasibility studies; Development of pharmaceutical preparations and medicines; Drug discovery services; Genetic testing for scientific research purposes; Providing medical and scientific research information; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Providing information in the field of clinical research via a website; Providing medical and scientific research information in the field of clinical trials; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Research and development in the pharmaceutical and biotechnology fields; Research on the subject of pharmaceuticals; Scientific research in the nature of conducting clinical trials for others in the field of RNA therapeutics; Testing, inspection, research, or development of pharmaceutical preparations for gene therapy |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, March 14, 2022 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | WYVERNA THERAPEUTICS, INC. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Sherborn, MA 01770 |
| Party Name | WYVERNA THERAPEUTICS, INC. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Sherborn, MA 01770 |
| Event Date | Event Description |
| Tuesday, February 20, 2024 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| Monday, February 19, 2024 | ABANDONMENT - NO USE STATEMENT FILED |
| Tuesday, July 18, 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Sunday, June 4, 2023 | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED |
| Tuesday, January 24, 2023 | EXTENSION OF TIME TO OPPOSE RECEIVED |
| Tuesday, January 24, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, January 24, 2023 | PUBLISHED FOR OPPOSITION |
| Wednesday, January 4, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Wednesday, December 21, 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, December 21, 2022 | EXAMINER'S AMENDMENT ENTERED |
| Wednesday, December 21, 2022 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Wednesday, December 21, 2022 | EXAMINERS AMENDMENT E-MAILED |
| Wednesday, December 21, 2022 | EXAMINERS AMENDMENT -WRITTEN |
| Tuesday, December 20, 2022 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, December 20, 2022 | NON-FINAL ACTION E-MAILED |
| Tuesday, December 20, 2022 | NON-FINAL ACTION WRITTEN |
| Monday, December 19, 2022 | LETTER OF PROTEST EVIDENCE REVIEWED-NO FURTHER ACTION TAKEN |
| Sunday, December 18, 2022 | ASSIGNED TO EXAMINER |
| Thursday, June 16, 2022 | LETTER OF PROTEST EVIDENCE FORWARDED |
| Monday, March 14, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, March 11, 2022 | NEW APPLICATION ENTERED |